In a subpopulation of glioma stem cell-like cells identified as recurrence-initiating stem-like cancer (RISC) cells, IGF-IR maintains cell survival through an autocrine activation that downregulates both AKT and ERK signaling leading to slow-growth but high-self-renewal (38, 39). The gene discussed is MAPK1; the disease is glioma.